Is CHARAN-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CHARAN-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CHARAN-R (THB22.5) is trading above our estimate of fair value (THB4.89)
Significantly Below Fair Value: CHARAN-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CHARAN-R?
Key metric: As CHARAN-R is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for CHARAN-R. This is calculated by dividing CHARAN-R's market cap by their current
revenue.
What is CHARAN-R's PS Ratio?
PS Ratio
0.9x
Sales
฿294.54m
Market Cap
฿270.00m
CHARAN-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue
0.6x
Enterprise Value/EBITDA
-32.1x
PEG Ratio
n/a
Price to Sales Ratio vs Peers
How does CHARAN-R's PS Ratio compare to its peers?
Price-To-Sales vs Industry: CHARAN-R is expensive based on its Price-To-Sales Ratio (0.9x) compared to the Asian Insurance industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is CHARAN-R's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
CHARAN-R PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.9x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CHARAN-R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.